Smart4Diagnostics

Smart4Diagnostics, formerly known as DX-Labtrack, is a manufacturing startup founded in 2018 with a clear mission encapsulated in their slogan: "Smart4Diagnostics improves diagnostic decision making with evidence-based preanalytics and digital sample fingerprint for patient safety." The company is revolutionizing the diagnostic decision-making process by addressing the data gap between blood collection and lab analysis. Their recent accomplishment includes securing a notable €3.60MConvertible Note investment on 09 May 2023 from VP Venture Partners and SARSTEDT, showcasing validation and confidence from established investors. Smart4Diagnostics' cutting-edge technology is designed to transform the trust-based preanalytics system into an evidence-based framework, significantly enhancing patient safety, medical decision-making quality, and lab testing efficiency. Their digital human sample fingerprint is touted to set the new standard, ensuring a trustworthy and verifiable foundation for the future of personalized medicine. In the manufacturing industry, Smart4Diagnostics stands out as a promising player with a clear vision and innovative approach, backed by notable investor support.